These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35472074)

  • 61. [Study of dopamine transporter imaging on the brain of children with autism].
    Sun X; Yue J; Zheng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr; 25(2):327-30. PubMed ID: 18610616
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study.
    Yang YK; Yeh TL; Yao WJ; Lee IH; Chen PS; Chiu NT; Lu RB
    Psychiatry Res; 2008 Apr; 162(3):230-5. PubMed ID: 18295460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
    Schneier FR; Abi-Dargham A; Martinez D; Slifstein M; Hwang DR; Liebowitz MR; Laruelle M
    Depress Anxiety; 2009; 26(5):411-8. PubMed ID: 19180583
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lower dopamine transporter density in an asymptomatic patient with Kleine-Levin syndrome.
    Hoexter MQ; Shih MC; Mendes DD; Godeiro-Junior C; Felicio AC; Fu YK; Tufik S; Bressan RA
    Acta Neurol Scand; 2008 May; 117(5):370-3. PubMed ID: 18028505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
    Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
    World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dopamine transporter binding in females with panic disorder may vary with clinical status.
    Maron E; Nutt DJ; Kuikka J; Tiihonen J
    J Psychiatr Res; 2010 Jan; 44(1):56-9. PubMed ID: 19467545
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Voxel-based analysis of age and gender effects on striatal [
    Shigemoto Y; Matsuda H; Kimura Y; Chiba E; Ohnishi M; Nakaya M; Maikusa N; Ogawa M; Mukai Y; Takahashi Y; Sako K; Toyama H; Inui Y; Taki Y; Nagayama H; Ono K; Kono A; Sekiguchi K; Hirano S; Sato N
    Ann Nucl Med; 2022 May; 36(5):460-467. PubMed ID: 35174441
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers.
    Hsieh PC; Yeh TL; Lee IH; Huang HC; Chen PS; Yang YK; Chiu NT; Lu RB; Liao MH
    J Psychiatry Neurosci; 2010 Mar; 35(2):90-4. PubMed ID: 20184806
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
    Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
    Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults.
    Smith CT; San Juan MD; Dang LC; Katz DT; Perkins SF; Burgess LL; Cowan RL; Manning HC; Nickels ML; Claassen DO; Samanez-Larkin GR; Zald DH
    Transl Psychiatry; 2018 Dec; 8(1):269. PubMed ID: 30531858
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Striatal dopamine transporter availability in unmedicated bipolar disorder.
    Anand A; Barkay G; Dzemidzic M; Albrecht D; Karne H; Zheng QH; Hutchins GD; Normandin MD; Yoder KK
    Bipolar Disord; 2011 Jun; 13(4):406-13. PubMed ID: 21843280
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Striatal dopamine transporter changes after glucose loading in humans.
    Pak K; Seo S; Kim K; Lee MJ; Shin MJ; Suh S; Im HJ; Park JJ; Kim SJ; Kim IJ
    Diabetes Obes Metab; 2020 Jan; 22(1):116-122. PubMed ID: 31478329
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
    Krause J
    Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent.
    Jensen ME; Galli A; Thomsen M; Jensen KL; Thomsen GK; Klausen MK; Vilsbøll T; Christensen MB; Holst JJ; Owens A; Robertson S; Daws L; Zanella D; Gether U; Knudsen GM; Fink-Jensen A
    Neurochem Int; 2020 Sep; 138():104772. PubMed ID: 32464226
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.
    Mateos JJ; Lomeña F; Parellada E; Mireia F; Fernandez-Egea E; Pavia J; Prats A; Pons F; Bernardo M
    Psychopharmacology (Berl); 2007 Apr; 191(3):805-11. PubMed ID: 17019564
    [TBL] [Abstract][Full Text] [Related]  

  • 80. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers.
    van de Giessen E; Hesse S; Caan MW; Zientek F; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Guignard R; Akdemir UO; Knudsen GM; Nobili F; Pagani M; Vander Borght T; Van Laere K; Varrone A; Tatsch K; Booij J; Sabri O
    Neuroimage; 2013 Jan; 64():61-7. PubMed ID: 22982354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.